Skip to main content
  1. aggrego News
  2. Solid Tumors

Early Changes in ctDNA May Predict Treatment Outcomes in Advanced Cancer

Recommended
Men at Higher Risk Than Women for Many Cancers: Why?
Clonal Diversification and Histogenesis of Malignant Germ Cell Tumors
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity
Safety, Tolerability and Efficacy of Agonist Anti-CD27 Antibody (Varlilumab) Administered in Combination With Anti-PD-1 (Nivolumab) in Advanced Solid Tumors
Therapeutic Targeting of PD-1/PD-L1 Blockade by Novel Small-Molecule Inhibitors Recruits Cytotoxic T Cells Into Solid Tumor Microenvironment
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors 
A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis
Early Changes in ctDNA May Predict Treatment Outcomes in Advanced Cancer

Early Changes in ctDNA May Predict Treatment Outcomes in Advanced Cancer

header-info
Aug, 01, 2022
social-elements

Detection of circulating tumor DNA (ctDNA) and early changes in ctDNA levels are predictive of systemic treatment outcomes in patients with advanced solid tumors, according to research published in JCO Precision Medicine.

Footer branding


Footer main navigation

  • About Us
  • Contact Us
  • Privacy Policy
  • Sign in

HMP Global Products

  • HMP Global Learning Network
  • Consultant360
  • VRTX

Copyright branding

© 2022 HMP Global. Aggrego is a trademark of HMP Global. All Rights Reserved.

<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->

Home

Site branding - mobile

Upper navigation

  • Today
    Today
  • Following
    Following
  • Specialties
    Specialties

Main navigation

  • News
    news
  • TV
    TV
  • Radio
    Radio
  • Conference Hub
    Conf hub

Partners links

  • Advances
    Advances Menu

User imageSign in

Register

Additional navigation- 1

  • Acute Basal Cell Carcinoma
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • AML+CLL
  • Breast Cancer
  • CAR-T Cell Therapy
  • Chronic ITP
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Cutaneous Squamous-Cell Carcinoma
  • Diffuse Large B-Cell Lymphoma
  • Early Breast Cancer
  • FDA Approvals
  • Febrile Neutropenia
  • Follicular Lymphoma
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Graft Versus Host Disease
  • Gynecologic Cancer
  • Head And Neck Cancer
  • Healthcare Policy
  • Hematologic Malignancies
  • HER2 Low mBC
  • Immuno Oncology

Additional navigation- 2

  • Liver Cancer
  • Lung Cancer
  • Marginal Zone Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Non-Small-Cell Lung Cancer
  • Oncology Nursing
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pediatric Oncology
  • Prostate Cancer
  • Radiation Oncology
  • Renal Cell Carcinoma
  • RET+ Advanced Thyroid Cancer
  • RET+ NSCLC
  • Sarcoma
  • Skin Cancer
  • Solid Tumors
  • Supportive Care
  • Surgical Cancer
  • Urethral Carcinoma

Advances menu

  • KEYNOTE-522 Trial
  • Pancreatic Cancer Action Network: Precision Promise Trial